The 2027–2033 Patent Cliff: Turning Post-Patent Opportunities into Pipeline Success
Between 2027 and 2033, the pharmaceutical industry will face one of the largest waves of loss of exclusivity (LOE) events in its history. Industry analyses indicate that nearly 200 drugs are expected to lose patent protection by 2030.